We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Microsoft, Procter & Gamble, Intel and Apple
Read MoreHide Full Article
For Immediate Release
Chicago, IL – March 4, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Microsoft Corp. (MSFT - Free Report) , The Procter & Gamble Company (PG - Free Report) , Intel Corp. (INTC - Free Report) and Apple Inc. (AAPL - Free Report) .
Here are highlights from Tuesday’s Analyst Blog:
Dow Makes a Comeback on Stimulus Hopes: 4 Blue-Chip Picks
The Dow Jones Industrial Average recorded its biggest one-day percentage gain in almost 11 years on Mar 2, as stocks rebounded from the worst weekly slide on Feb 28 since October 2008. In fact, last Thursday, the blue-chip index had closed in the correction territory, which is defined as a drop of at least 10% from a recent peak. What’s more, last week saw the Dow fall 12.4%.
Nonetheless, the Dow bounced back on expectations that policy makers across the globe will take appropriate policies to curtail the impact of the coronavirus outbreak on corporate profit margins and the global economy.
Fed Chairman Jerome Powell recently said that the central bank is “closely monitoring” the outbreak. He added that “we will use our tools and act as appropriate to support the economy.” And traders are now expecting the Fed to cut rates at least by 75 basis points through April. Bank of Japan Governor Haruhiko Kuroda added that we “will strive to provide ample liquidity and ensure stability in financial markets through appropriate market operations and asset purchases.”
Australian central bank’s governor in the meantime acknowledged that the coronavirus outbreak does have a “significant effect” on the country’s economy and any move to ease monetary policy will certainly “provide additional support to employment and economic activity.” And the Reserve Bank of Australia has already announced a cut in its cash rate by 25 basis points to 0.5%, an all-time low. European Central Bank President Christine Lagarde also assured that the bank is monitoring the outbreak and will take “appropriate” steps if required.
Randy Frederick, vice president of trading and derivatives for the Schwab Center for Financial Research, added that “there is willingness on the part of the Fed and other central banks in the world to lower rates” to stimulate the global economy. Meanwhile, Goldman Sachs chief economist Jan Hatzius expects most of the central banks for G10 countries to trim rates.
By the way, finance ministers from the Group of Seven economies are scheduled to hold talks today to discuss the probable responses to the deadly virus. Powell and Treasury Secretary Steven Mnuchin will lead the G-7 and they expect a “coordinated effort” to curb the impact of the coronavirus (read more: Coronavirus Fears Holding You Back? 3 Smart Ways to Invest).
4 Blue-Chip Stocks to Buy Now
Thanks to the aforementioned factors, the 120-year-old index of 30 stocks is widely expected to climb north. And these companies are slated to gain in the near term as they have large market capitalization, strong balance sheet and solid cash flow. Hence, it makes sense to invest in solid blue-chip stocks that can make the most of a Dow rally. We have selected four such blue-chip stocks that have a Zacks Rank #1 (Strong Buy) or 2 (Buy).
Microsoft Corp. has a Zacks Rank #1. The enterprise refresh cycle, new subscription model, Azure and promising new products will continue to generate sizeable cash flows. The Zacks Consensus Estimate for its current-year earnings has moved up 5% over the past 60 days. The company’s expected earnings growth rate for the current quarter and year is 15.8% and 18.3%, respectively.
The Procter & Gamble Company has a Zacks Rank #2. Driven by strong organic sales growth, core earnings and returns to shareholders, the company raised its view for fiscal 2020. The Zacks Consensus Estimate for its current-year earnings has moved 0.8% north over the past 60 days. The company’s expected earnings growth rate for the current quarter and year is 3.8% and 10.1%, respectively.
Intel Corp. has a Zacks Rank #2. The company’s leading position in PC market, strength in servers and growing software business are positive indicators of future growth prospects. The Zacks Consensus Estimate for its current-year earnings has advanced 5.7% over the past 60 days. The company’s expected earnings growth rate for the current and next quarter is 47.2% and 18.9%, respectively. You can see the complete list of today’s Zacks #1 Rank stocks here.
Apple Inc. has a Zacks Rank #2. The company is witnessing an increase in sales of smartwatches, AirPods wireless earbuds and services like mobile payments and streaming-music subscriptions of late. The Zacks Consensus Estimate for its current-year earnings has climbed 4.2% over the past 60 days. The company’s expected earnings growth rate for the current and next quarter is 11.8% and 14.8%, respectively.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Microsoft, Procter & Gamble, Intel and Apple
For Immediate Release
Chicago, IL – March 4, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Microsoft Corp. (MSFT - Free Report) , The Procter & Gamble Company (PG - Free Report) , Intel Corp. (INTC - Free Report) and Apple Inc. (AAPL - Free Report) .
Here are highlights from Tuesday’s Analyst Blog:
Dow Makes a Comeback on Stimulus Hopes: 4 Blue-Chip Picks
The Dow Jones Industrial Average recorded its biggest one-day percentage gain in almost 11 years on Mar 2, as stocks rebounded from the worst weekly slide on Feb 28 since October 2008. In fact, last Thursday, the blue-chip index had closed in the correction territory, which is defined as a drop of at least 10% from a recent peak. What’s more, last week saw the Dow fall 12.4%.
Nonetheless, the Dow bounced back on expectations that policy makers across the globe will take appropriate policies to curtail the impact of the coronavirus outbreak on corporate profit margins and the global economy.
Fed Chairman Jerome Powell recently said that the central bank is “closely monitoring” the outbreak. He added that “we will use our tools and act as appropriate to support the economy.” And traders are now expecting the Fed to cut rates at least by 75 basis points through April. Bank of Japan Governor Haruhiko Kuroda added that we “will strive to provide ample liquidity and ensure stability in financial markets through appropriate market operations and asset purchases.”
Australian central bank’s governor in the meantime acknowledged that the coronavirus outbreak does have a “significant effect” on the country’s economy and any move to ease monetary policy will certainly “provide additional support to employment and economic activity.” And the Reserve Bank of Australia has already announced a cut in its cash rate by 25 basis points to 0.5%, an all-time low. European Central Bank President Christine Lagarde also assured that the bank is monitoring the outbreak and will take “appropriate” steps if required.
Randy Frederick, vice president of trading and derivatives for the Schwab Center for Financial Research, added that “there is willingness on the part of the Fed and other central banks in the world to lower rates” to stimulate the global economy. Meanwhile, Goldman Sachs chief economist Jan Hatzius expects most of the central banks for G10 countries to trim rates.
By the way, finance ministers from the Group of Seven economies are scheduled to hold talks today to discuss the probable responses to the deadly virus. Powell and Treasury Secretary Steven Mnuchin will lead the G-7 and they expect a “coordinated effort” to curb the impact of the coronavirus (read more: Coronavirus Fears Holding You Back? 3 Smart Ways to Invest).
4 Blue-Chip Stocks to Buy Now
Thanks to the aforementioned factors, the 120-year-old index of 30 stocks is widely expected to climb north. And these companies are slated to gain in the near term as they have large market capitalization, strong balance sheet and solid cash flow. Hence, it makes sense to invest in solid blue-chip stocks that can make the most of a Dow rally. We have selected four such blue-chip stocks that have a Zacks Rank #1 (Strong Buy) or 2 (Buy).
Microsoft Corp. has a Zacks Rank #1. The enterprise refresh cycle, new subscription model, Azure and promising new products will continue to generate sizeable cash flows. The Zacks Consensus Estimate for its current-year earnings has moved up 5% over the past 60 days. The company’s expected earnings growth rate for the current quarter and year is 15.8% and 18.3%, respectively.
The Procter & Gamble Company has a Zacks Rank #2. Driven by strong organic sales growth, core earnings and returns to shareholders, the company raised its view for fiscal 2020. The Zacks Consensus Estimate for its current-year earnings has moved 0.8% north over the past 60 days. The company’s expected earnings growth rate for the current quarter and year is 3.8% and 10.1%, respectively.
Intel Corp. has a Zacks Rank #2. The company’s leading position in PC market, strength in servers and growing software business are positive indicators of future growth prospects. The Zacks Consensus Estimate for its current-year earnings has advanced 5.7% over the past 60 days. The company’s expected earnings growth rate for the current and next quarter is 47.2% and 18.9%, respectively. You can see the complete list of today’s Zacks #1 Rank stocks here.
Apple Inc. has a Zacks Rank #2. The company is witnessing an increase in sales of smartwatches, AirPods wireless earbuds and services like mobile payments and streaming-music subscriptions of late. The Zacks Consensus Estimate for its current-year earnings has climbed 4.2% over the past 60 days. The company’s expected earnings growth rate for the current and next quarter is 11.8% and 14.8%, respectively.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
http://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.